Skip to content

QuarterlyIQ Insights · XYL

News & Events

Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.

Type
Direction
9 matches
  1. 2026-04-28Item 2.02

    Results of Operations and Financial Condition On April 28, 2026, Xylem Inc. issued a press release announcing its financial results for the quarter ended March 31, 2026. A copy of the press release is furnished as Exhibit 99.1 to this report and is incorporated by reference herein. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference into any filing under the Securities Act…

    earnings preannouncementearnings inlineneutralscore 67
  2. 2026-02-25Item 8.01

    Other Events On February 25, 2026, the Board of Directors of Xylem Inc. (the “Company”) approved the adoption of a new share repurchase program. Under the new program, which has no expiration date, the Company is authorized to purchase up to $1.5 billion in shares of the common stock, $0.01 par value, of the Company (“Common Stock”). Repurchases under the new program may be made through open market purchases or otherwise (in compliance with all applicable laws and regulations in effect from t…

    capital allocationbuyback announcedpositivescore 52
  3. 2026-02-10Item 2.02

    Results of Operations and Financial Condition On February 10, 2026, Xylem Inc. issued a press release announcing its financial results for the quarter and fiscal year ended December 31, 2025. A copy of the press release is furnished as Exhibit 99.1 to this report and is incorporated by reference herein. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference into any filing un…

    earnings preannouncementearnings inlineneutralscore 67
  4. 2025-01-30Item 2.02

    Results of Operations and Financial Condition On January 30, 2025, Xylem Inc. (the “Company”) confirmed that its financial results for the quarter and year ended December 31, 2024 will be largely in line with or above guidance for the quarter and year ended December 31, 2024 that was provided by the Company in its earnings announcement on October 31, 2024. This information in this

    earnings preannouncementearnings inlineneutralscore 67
  5. 2025-01-30Item 2.05

    Cost Associated with Exit or Disposal Activities On January 28, 2025, at the delegation of the Company’s Board of Directors, management committed to a restructuring plan. The plan consists of workforce reductions across all of our businesses and functions. Consistent with our 2024 Investor Day highlights around simplification to achieve our strategy, this plan is designed to streamline our organization, which will strengthen our competitive positioning and ability to better serve our customer…

    product or strategy shiftrestructuringneutralscore 62
  6. 2025-01-15Item 5.02

    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 10, 2025, Jeanne Beliveau-Dunn informed the Board of Directors (the “Board”) of Xylem Inc. (the “Company”) of her decision not to stand for re-election as a Director of the Company at the Company’s 2025 annual meeting of shareholders (“2025 Annual Meeting”). Ms. Beliveau-Dunn’s decision not to stand for re-election is not because of any…

    executive changeofficer changeneutralscore 57
  7. 2023-02-10Item 7.01

    Regulation FD Disclosure On February 10, 2023, Patrick K. Decker, President and Chief Executive Officer of Xylem Inc. (the “Company”), entered into a pre-arranged trading plan (the “Plan”) in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the Company’s policies, including those with respect to insider trading and stock ownership. The Plan is part of Mr. Decker’s individual long-term asset diversification and financial planning strat…

    mna activityacquisition completedpositivescore 52
  8. 2022-05-12Item 5.02

    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Effective May 11, 2022, Jorge M. Gomez resigned as a director of Xylem Inc. (the “Company”). Mr. Gomez’s resignation from the Company’s Board of Directors (the “Board”) did not result from any disagreement with the Company on any matter, including relating to its operations, policies or practices. In connection with Mr. Gomez’s resignation, the siz…

    executive changedirector transitionneutralscore 57
  9. 2021-06-09Item 7.01

    Regulation FD Disclosure On June 8, 2021, Patrick K. Decker, President and Chief Executive Officer of Xylem Inc. (the “Company”), entered into a pre-arranged trading plan (the “Plan”) in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the Company’s policies, including those with respect to insider trading and stock ownership. The Plan is part of Mr. Decker’s individual long-term asset diversification and financial planning strategy.…

    mna activityacquisition completedpositivescore 52
Coming next

General-purpose headline news (a news API), full earnings call transcripts, and macro/sector items flagged when they directly affect this stock are not yet in the marts. Today this tab covers SEC filings surfaced via mart.stock_material_events_history.

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.